CANCER AND HEPATITIS C patients will receive better coverage under the universal healthcare scheme as the board of the National Health Security Office (NHSO) has approved an additional four expensive medicines for it.

At yesterday's meeting, the NHSO board approved the use of Trastuzumab, Peginterferon, Nilotinib and Dasatinib for patients seeking free treatments under the scheme.

The universal healthcare scheme covers about 49 million people in total across the country.